Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).
复制标题
DOI:
10.1093/neuonc/noab020
复制
发表时间:
2021-07-01
期刊:
影响因子:
15.9
通讯作者:
Hu LS
中科院分区:
文献类型:
--
作者:
Barajas RF;Politi LS;Anzalone N;Schöder H;Fox CP;Boxerman JL;Kaufmann TJ;Quarles CC;Ellingson BM;Auer D;Andronesi OC;Ferreri AJM;Mrugala MM;Grommes C;Neuwelt EA;Ambady P;Rubenstein JL;Illerhaus G;Nagane M;Batchelor TT;Hu LS
Advanced molecular and pathophysiologic characterization of primary central nervous system lymphoma (PCNSL) has revealed insights into promising targeted therapeutic approaches. Medical imaging plays a fundamental role in PCNSL diagnosis, staging, and response assessment. Institutional imaging variation and inconsistent clinical trial reporting diminishes the reliability and reproducibility of clinical response assessment. In this context, we aimed to: (1) critically review the use of advanced positron emission tomography (PET) and magnetic resonance imaging (MRI) in the setting of PCNSL; (2) provide results from an international survey of clinical sites describing the current practices for routine and advanced imaging, and (3) provide biologically based recommendations from the International PCNSL Collaborative Group (IPCG) on adaptation of standardized imaging practices. The IPCG provides PET and MRI consensus recommendations built upon previous recommendations for standardized brain tumor imaging protocols (BTIP) in primary and metastatic disease. A biologically integrated approach is provided to addresses the unique challenges associated with the imaging assessment of PCNSL. Detailed imaging parameters facilitate the adoption of these recommendations by researchers and clinicians. To enhance clinical feasibility, we have developed both “ideal” and “minimum standard” protocols at 3T and 1.5T MR systems that will facilitate widespread adoption.
登录
查看更多内容
DOI:
10.2463/mrms.mp.2017-0135
发表时间:
2019-01-10
期刊:
Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine
影响因子:
--
作者:
Bao S;Watanabe Y;Takahashi H;Tanaka H;Arisawa A;Matsuo C;Wu R;Fujimoto Y;Tomiyama N
通讯作者:
Tomiyama N
影响因子:
--
作者:
Bowden SG;Munger DN;Thiessen J;Woll SCS;Han SJ;Neuwelt EA;Barajas RF;Ambady P
通讯作者:
Ambady P
影响因子:
19.7
作者:
Guo, AC;Cummings, TJ;Provenzale, JM
通讯作者:
Provenzale, JM
DOI:
10.3174/ajnr.a1750
发表时间:
2010-01
期刊:
AJNR. American journal of neuroradiology
影响因子:
--
作者:
Barajas RF Jr;Rubenstein JL;Chang JS;Hwang J;Cha S
通讯作者:
Cha S
影响因子:
3.5
作者:
Hu, L. S.;Baxter, L. C.;Heiserman, J. E.
通讯作者:
Heiserman, J. E.